Published in Pharm Res on October 01, 1999
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm Res (2007) 1.39
Effects of size and topology of DNA molecules on intracellular delivery with non-viral gene carriers. BMC Biotechnol (2008) 0.89
Characterization of complexation of poly (N-isopropylacrylamide-co-2-(dimethylamino) ethyl methacrylate) thermoresponsive cationic nanogels with salmon sperm DNA. Int J Nanomedicine (2009) 0.77
Hydrolytic charge-reversal of PEGylated polyplexes enhances intracellular un-packaging and activity of siRNA. J Biomed Mater Res A (2016) 0.76
Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res (2000) 2.17
Cationic polymer based gene delivery systems. Pharm Res (2000) 1.98
Tumour-targeted nanomedicines: principles and practice. Br J Cancer (2008) 1.81
Liposomal and lipid formulations of amphotericin B. Clinical pharmacokinetics. Clin Pharmacokinet (1992) 1.74
Triggered destabilisation of polymeric micelles and vesicles by changing polymers polarity: an attractive tool for drug delivery. J Control Release (2007) 1.45
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm Res (2007) 1.39
Lymphatic uptake and biodistribution of liposomes after subcutaneous injection. II. Influence of liposomal size, lipid compostion and lipid dose. Biochim Biophys Acta (1997) 1.35
Chemical stability of liposomes: implications for their physical stability. Chem Phys Lipids (1993) 1.24
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer (2008) 1.23
Structure-activity relationships of water-soluble cationic methacrylate/methacrylamide polymers for nonviral gene delivery. Bioconjug Chem (1999) 1.22
Adhesion molecules: a new target for immunoliposome-mediated drug delivery. FEBS Lett (1995) 1.16
The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release (2000) 1.14
Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice. J Gene Med (2004) 1.10
Physically crosslinked dextran hydrogels by stereocomplex formation of lactic acid oligomers: degradation and protein release behavior. J Control Release (2001) 1.09
Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem (2002) 1.07
Thermosensitive polymers as carriers for DNA delivery. J Control Release (1999) 1.04
2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J Control Release (1998) 1.04
Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J Control Release (1999) 1.03
Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res (1987) 1.01
Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm Res (1996) 1.01
Physical (in) stability of liposomes upon chemical hydrolysis: the role of lysophospholipids and fatty acids. Biochim Biophys Acta (1995) 1.00
The role of protein charge in protein-lipid interactions. pH-dependent changes of the electrophoretic mobility of liposomes through adsorption of water-soluble, globular proteins. Biochemistry (1993) 1.00
Controlled release of a model protein from enzymatically degrading dextran microspheres. J Control Release (1999) 1.00
In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts. Biomaterials (2001) 0.99
Liposomes and ISCOMS as vaccine formulations. Biochim Biophys Acta (1995) 0.99
Sterically stabilized liposomes labeled with indium-111 to image focal infection. J Nucl Med (1995) 0.99
An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems. J Gene Med (2005) 0.98
Photopolymerized thermosensitive hydrogels for tailorable diffusion-controlled protein delivery. J Control Release (2009) 0.98
Influence of neutron irradiation on holmium acetylacetonate loaded poly(L-lactic acid) microspheres. Biomaterials (2002) 0.98
Production of GMP-grade radioactive holmium loaded poly(L-lactic acid) microspheres for clinical application. Int J Pharm (2006) 0.97
The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int J Pharm (2001) 0.97
Micelles based on HPMA copolymers. Adv Drug Deliv Rev (2009) 0.96
On the structure of immune-stimulating saponin-lipid complexes (iscoms). Biochim Biophys Acta (1991) 0.96
Immunogenic activity of gonococcal protein I in mice with three different lipoidal adjuvants delivered in liposomes and in complexes. Infect Immun (1986) 0.94
Intravenous administration of superoxide dismutase entrapped in long circulating liposomes. II. In vivo fate in a rat model of adjuvant arthritis. Biochim Biophys Acta (1999) 0.94
The preparation of tissue-type Plasminogen Activator (t-PA) containing liposomes: entrapment efficiency and ultracentrifugation damage. J Drug Target (1995) 0.94
Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. Biochim Biophys Acta (2001) 0.93
The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) with and without hydrolytically sensitive groups. Biomaterials (2004) 0.93
Effect of molecular weight and glass transition on relaxation and release behaviour of poly(DL-lactic acid) tablets. J Control Release (2001) 0.92
Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release (2000) 0.92
Cellular uptake of liposomes targeted to intercellular adhesion molecule-1 (ICAM-1) on bronchial epithelial cells. Biochim Biophys Acta (1999) 0.92
Degradation kinetics of methacrylated dextrans in aqueous solution. J Pharm Sci (1997) 0.92
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J Control Release (2003) 0.91
Detecting infection and inflammation with technetium-99m-labeled Stealth liposomes. J Nucl Med (1996) 0.91
Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonate. Biomaterials (2001) 0.90
Chemical hydrolysis of phospholipids. J Pharm Sci (1995) 0.90
Water-soluble biodegradable cationic polyphosphazenes for gene delivery. J Control Release (2003) 0.89
Hydrolysis of saturated soybean phosphatidylcholine in aqueous liposome dispersions. J Pharm Sci (1993) 0.89
The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim Biophys Acta (1985) 0.88
Preparation of liposomes via detergent removal from mixed micelles by dilution. The effect of bilayer composition and process parameters on liposome characteristics. Pharm Weekbl Sci (1986) 0.88
Short term stability of freeze-dried, lyoprotected liposomes. J Control Release (1999) 0.88
Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study. Biomed Microdevices (2009) 0.88
Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells. Adv Drug Deliv Rev (2010) 0.88
The use of aqueous PEG/dextran phase separation for the preparation of dextran microspheres. Int J Pharm (1999) 0.87
Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J Control Release (1999) 0.86
Colloidal systems for tumor targeting. Hybridoma (1997) 0.86
Fourier transform infrared spectrometric analysis of protein conformation: effect of sampling method and stress factors. Anal Biochem (2001) 0.86
Chloroquine containing liposomes in the chemotherapy of murine malaria. Parasitology (1989) 0.86
The effect of aging on the physical stability of liposome dispersions. Chem Phys Lipids (1992) 0.86
Removal of chloroform from biodegradable therapeutic microspheres by radiolysis. Int J Pharm (2006) 0.85
Reduced cardiotoxicity and nephrotoxicity with preservation of antitumor activity of doxorubicin entrapped in stable liposomes in the LOU/M Wsl rat. Cancer Res (1984) 0.85
Microspheres with ultrahigh holmium content for radioablation of malignancies. Pharm Res (2009) 0.85
Thrombolytic treatment with tissue-type plasminogen activator (t-PA) containing liposomes in rabbits: a comparison with free t-PA. Thromb Haemost (1995) 0.85
Liposomes containing interferon-gamma as adjuvant in tumor cell vaccines. Pharm Res (2000) 0.85
Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid). J Control Release (2009) 0.85
Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells. Cancer Gene Ther (2001) 0.84
Analytical approaches to the study of monoclonal antibody stability. Pharm Res (1990) 0.84
Hydrolysis of partially saturated egg phosphatidylcholine in aqueous liposome dispersions and the effect of cholesterol incorporation on hydrolysis kinetics. J Pharm Pharmacol (1993) 0.84
The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics. Pharm Res (1998) 0.84
Immunoliposome-mediated targeting of doxorubicin to human ovarian carcinoma in vitro and in vivo. Br J Cancer (1996) 0.84
In vivo targeting of OV-TL 3 immunoliposomes to ascitic ovarian carcinoma cells (OVCAR-3) in athymic nude mice. Cancer Res (1992) 0.83
Release of doxorubicin from peritoneal macrophages exposed in vivo to doxorubicin-containing liposomes. Biochim Biophys Acta (1988) 0.83
The influence of sucrose, dextran, and hydroxypropyl-beta-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12). Pharm Res (1992) 0.83
Renal targeting of kinase inhibitors. Int J Pharm (2008) 0.83
Degradable PEG-folate coated poly(DMAEA-co-BA)phosphazene-based polyplexes exhibit receptor-specific gene expression. Eur J Pharm Sci (2007) 0.83
In vivo biocompatibility of dextran-based hydrogels. J Biomed Mater Res (2000) 0.83
Gamma-irradiation damage to liposomes differing in composition and their protection by nitroxides. Free Radic Biol Med (1997) 0.83
Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations. Vaccine (1995) 0.83
Non-random conformation of a mouse IgG2a monoclonal antibody at low pH. Eur J Biochem (1991) 0.83
Effects of physicochemical characteristics of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalization. J Drug Target (2000) 0.83
Influence of lipid composition and ionic strength on the physical stability of liposomes. J Pharm Sci (1984) 0.82
Effect of freezing rate on the stability of liposomes during freeze-drying and rehydration. Pharm Res (1997) 0.82
The downmodulation of the foreign body reaction by cytomegalovirus encoded interleukin-10. Biomaterials (2008) 0.82
On the interaction between a bactericidal antibody and a PorA epitope of Neisseria meningitidis in outer membrane vesicles: a competitive fluorescence polarization immunoassay. Anal Biochem (1997) 0.82
Therapeutic effect of chloroquine(CQ)-containing immunoliposomes in rats infected with Plasmodium berghei parasitized mouse red blood cells: comparison with combinations of antibodies and CQ or liposomal CQ. Biochim Biophys Acta (1989) 0.82